According to government data released overnight, there are now 2,011 confirmed cases of Ebola in the Congo, including 754 deaths. This is the fastest-growing outbreak on record, according to authorities, despite the fact that some health workers have gone on strike due to salary concerns.
According to data from Congo's Ministry of Health, 366 individuals have recovered thus far, while 753 people are still in hospitals or isolation.Contact tracking is still difficult, with just 67% of those exposed being covered.Since May 15, the country in Central Africa has been fighting an Ebola outbreak brought on by the uncommon Bundibugyo virus.
Despite a growing response, the outbreak is still spreading more quickly than health officials can monitor two months after it started.The World Health Organization reported on Tuesday that at least 80% of new cases are coming from unidentified routes of transmission.
One major issue is that the outbreak's patient zero has not yet been identified by health authorities, and it has been challenging to track down thousands of people who have come into touch with infected people due to displacement from armed conflict and mining-related migrations.
Dr. Chikwe Ihekweazu, the WHO health emergency chief, stated on Tuesday after returning from Bunia in Ituri, the province most severely affected by the outbreak, that many of the recently reported deaths were persons who passed away in their communities without ever visiting a medical institution and without receiving assistance.
In many parts of Ituri, health professionals are also going on strike.
Since they began working at the beginning of the outbreak, some have told The Associated Press they have not been paid.
The absence of licensed vaccinations or treatments for the Bundibugyo virus, in contrast to the more prevalent Zaire virus, which has a vaccine and was the cause of the majority of the disease's 16 outbreaks in Congo, has further complicated response efforts.
Recently, enrollment began in Ituri for a highly anticipated trial of two potential Ebola medicines.